Published Date：Mar.2021
Industry：Chemical & Material
Pages：113 Table Number：137
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Contract Pharmaceutical Manufacturing market in this environment. In terms of revenue, this research report indicated that the global Contract Pharmaceutical Manufacturing market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Contract Pharmaceutical Manufacturing industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Catalent aims at producing XX K Units Contract Pharmaceutical Manufacturing in 2020, with XX % production to take place in global market, DPx accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Contract Pharmaceutical Manufacturing Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Contract Pharmaceutical Manufacturing Market? Catalent DPx Lonza Piramal Healthcare Aenova Jubilant Famar Boehringer Ingelheim Fareva Holding AbbVie Nipro Corp Vetter Sopharma DPT Laboratories Recipharm NextPharma Dishman Aesica ... Major Type of Contract Pharmaceutical Manufacturing Covered in XYZResearch report: Active pharmaceutical ingredients (API) Finished dosage formulations (FDF) Application Segments Covered in XYZResearch Market Specialty/Midsize Generics Big Pharma Other For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Contract Pharmaceutical Manufacturing Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Active pharmaceutical ingredients (API) -Product Introduction and Major Manufacturers 1.1.2 Finished dosage formulations (FDF) -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Contract Pharmaceutical Manufacturing Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Contract Pharmaceutical Manufacturing Market 3.1.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Contract Pharmaceutical Manufacturing Market 3.2.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Contract Pharmaceutical Manufacturing Market 3.3.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Contract Pharmaceutical Manufacturing Market 3.4.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Contract Pharmaceutical Manufacturing Market 3.5.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Contract Pharmaceutical Manufacturing Market 3.6.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Contract Pharmaceutical Manufacturing Market 3.7.1 Top Companies leading Contract Pharmaceutical Manufacturing Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Contract Pharmaceutical Manufacturing Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Contract Pharmaceutical Manufacturing Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Contract Pharmaceutical Manufacturing Sales and Growth Rate (2021-2027) 5.2 Global Contract Pharmaceutical Manufacturing Sales Value and Growth Rate (2021-2027) 6 Contract Pharmaceutical Manufacturing Competitive Analysis 6.1 Catalent 6.1.1 Catalent Company Profiles 6.1.2 Catalent Product Introduction 6.1.3 Catalent Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 DPx 6.2.1 DPx Company Profiles 6.2.2 DPx Product Introduction 6.2.3 DPx Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Lonza 6.3.1 Lonza Company Profiles 6.3.2 Lonza Product Introduction 6.3.3 Lonza Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Piramal Healthcare 6.4.1 Piramal Healthcare Company Profiles 6.4.2 Piramal Healthcare Product Introduction 6.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Aenova 6.5.1 Aenova Company Profiles 6.5.2 Aenova Product Introduction 6.5.3 Aenova Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Jubilant 6.6.1 Jubilant Company Profiles 6.6.2 Jubilant Product Introduction 6.6.3 Jubilant Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Famar 6.7.1 Famar Company Profiles 6.7.2 Famar Product Introduction 6.7.3 Famar Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Boehringer Ingelheim 6.8.1 Boehringer Ingelheim Company Profiles 6.8.2 Boehringer Ingelheim Product Introduction 6.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Fareva Holding 6.9.1 Fareva Holding Company Profiles 6.9.2 Fareva Holding Product Introduction 6.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 AbbVie 6.10.1 AbbVie Company Profiles 6.10.2 AbbVie Product Introduction 6.10.3 AbbVie Contract Pharmaceutical Manufacturing Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 6.11 Nipro Corp 6.12 Vetter 6.13 Sopharma 6.14 DPT Laboratories 6.15 Recipharm 6.16 NextPharma 6.17 Dishman 6.18 Aesica 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Contract Pharmaceutical Manufacturing Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Contract Pharmaceutical Manufacturing Sales (K Unit) by Type (2026-2027) Figure Global Contract Pharmaceutical Manufacturing Sales (K Unit) and Growth Rate (2026-2027) Figure Global Contract Pharmaceutical Manufacturing Sales Market Share (%) by Type (2019 -2020) Table Global Contract Pharmaceutical Manufacturing Sales Value (Million USD) by Type (2026-2027) Figure Global Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Contract Pharmaceutical Manufacturing Sales Value Market Share (%) by Type (2019-2020) Table Global Contract Pharmaceutical Manufacturing Sales (K Unit) by Application (2026-2027) Table China Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table China Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table China Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure China Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table China Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table China Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table China Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure China Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Table EU Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table EU Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table EU Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure EU Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table EU Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table EU Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure EU Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Table USA Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table USA Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table USA Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure USA Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table USA Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table USA Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure USA Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Table Japan Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table Japan Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table Japan Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table Japan Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table Japan Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure Japan Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Table India Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table India Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table India Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure India Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table India Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table India Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table India Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure India Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Table Southeast Asia Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table Southeast Asia Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure Southeast Asia Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Table South America Contract Pharmaceutical Manufacturing Sales (K Unit) of Major Company (2016-2021) Table South America Contract Pharmaceutical Manufacturing Sales Market Share of Major Company (2016-2021) Table South America Contract Pharmaceutical Manufacturing Sales Value (Million USD) of Major Company (2016-2021) Figure South America Contract Pharmaceutical Manufacturing Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Contract Pharmaceutical Manufacturing Sales Value Share of Major Company (2016-2021) Table South America Contract Pharmaceutical Manufacturing Price (USD/Unit), by Type (2019-2020) Table South America Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure South America Contract Pharmaceutical Manufacturing Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Contract Pharmaceutical Manufacturing Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Contract Pharmaceutical Manufacturing Figure Cost Structure of Contract Pharmaceutical Manufacturing in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Contract Pharmaceutical Manufacturing Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Contract Pharmaceutical Manufacturing Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Catalent Profiles Table Catalent Contract Pharmaceutical Manufacturing Product Introduction Table Catalent Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Catalent SWOT Analysis Table DPx Profiles Table DPx Contract Pharmaceutical Manufacturing Product Introduction Table DPx Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure DPx SWOT Analysis Table Lonza Profiles Table Lonza Contract Pharmaceutical Manufacturing Product Introduction Table Lonza Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Lonza SWOT Analysis Table Piramal Healthcare Profiles Table Piramal Healthcare Contract Pharmaceutical Manufacturing Product Introduction Table Piramal Healthcare Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Piramal Healthcare SWOT Analysis Table Aenova Profiles Table Aenova Contract Pharmaceutical Manufacturing Product Introduction Table Aenova Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Aenova SWOT Analysis Table Jubilant Profiles Table Jubilant Contract Pharmaceutical Manufacturing Product Introduction Table Jubilant Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Jubilant SWOT Analysis Table Famar Profiles Table Famar Contract Pharmaceutical Manufacturing Product Introduction Table Famar Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Famar SWOT Analysis Table Boehringer Ingelheim Profiles Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Introduction Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Boehringer Ingelheim SWOT Analysis Table Fareva Holding Profiles Table Fareva Holding Contract Pharmaceutical Manufacturing Product Introduction Table Fareva Holding Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Fareva Holding SWOT Analysis Table AbbVie Profiles Table AbbVie Contract Pharmaceutical Manufacturing Product Introduction Table AbbVie Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AbbVie SWOT Analysis Table Nipro Corp Profiles Table Nipro Corp Contract Pharmaceutical Manufacturing Product Introduction Table Nipro Corp Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Nipro Corp SWOT Analysis Table Vetter Profiles Table Vetter Contract Pharmaceutical Manufacturing Product Introduction Table Vetter Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Vetter SWOT Analysis Table Sopharma Profiles Table Sopharma Contract Pharmaceutical Manufacturing Product Introduction Table Sopharma Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Sopharma SWOT Analysis Table DPT Laboratories Profiles Table DPT Laboratories Contract Pharmaceutical Manufacturing Product Introduction Table DPT Laboratories Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure DPT Laboratories SWOT Analysis Table Recipharm Profiles Table Recipharm Contract Pharmaceutical Manufacturing Product Introduction Table Recipharm Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Recipharm SWOT Analysis Table NextPharma Profiles Table NextPharma Contract Pharmaceutical Manufacturing Product Introduction Table NextPharma Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure NextPharma SWOT Analysis Table Dishman Profiles Table Dishman Contract Pharmaceutical Manufacturing Product Introduction Table Dishman Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Dishman SWOT Analysis Table Aesica Profiles Table Aesica Contract Pharmaceutical Manufacturing Product Introduction Table Aesica Contract Pharmaceutical Manufacturing Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
